Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology

INFO-AIDE-TABAC Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04333030

Enrollment

310

Registered

2020-04-03

Start date

2019-08-12

Completion date

2020-12-31

Last updated

2021-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consumption, Tobacco

Brief summary

this is an observational study that involves providing a questionnaire to patients consulting in psychiatry, addictology (other than tobacco) and endocrinology to assess their knowledge of tobacco risks and access to smoking cessation aids

Interventions

OTHERquestionnaire

Tobacco Use and Risk Questionnaire

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients \> 18 years * Men and women * who comes for consultation during the study * Psychiatry on CMP or HDJ, regardless of diagnosis or smoking status * Endocrinology in consultation or HDJ * In addictology at CSAPA

Exclusion criteria

* Patient unable to complete questionnaire (not speaking French, confused, alcoholics, etc.) * Refusal to complete questionnaire

Design outcomes

Primary

Measure	Time frame	Description
to Assess the level of information on tobacco-related risks of patients with questionnaire	at the end of study, average 2 month	to Assess the level of information on tobacco-related risks of patients monitored for psychiatric disorders by comparing them to patients monitored for an addiction other than tobacco or to patients monitored for a chronic disease
to Assess access to smoking cessation aids for smokers and ex-smokers with questionnaire	at the end of study, average 2 month	to Assess access to smoking cessation aids for smokers and ex-smokers among psychiatric patients compared to smokers and ex-smokers among patients who have been monitored for an addiction other than tobacco or among patients who have been monitored for a chronic disease (endocrine).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026